Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.
Synfini has raised $8.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Synfini's investors include Gaingels, Foothill Ventures, Mana Ventures, Trust Ventures, Ferocity Capital.
Synfini is headquartered in Menlo Park, United States.
Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.
Synfini is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synfini — Funding & Investors." VCBacked, July 7, 2025, https://www.vcbacked.co/company/synfini. Accessed September 11, 2026.
VCBacked. (2025). Synfini — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/synfini
{{cite web |title=Synfini — Funding & Investors |url=https://www.vcbacked.co/company/synfini |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated